Exhibitions and events
List of headings :
We are delighted to share that Quimigen will be participating in the upcoming event of "Converging Technologies for Biomolecular Systems (TeCSBi)" . It will take place at the University of Milan-Bicocca, Itazly, on September 16th and 17th 2024.
 |
We are honored to announce that Quimigen is sponsoring the "Lymphoma Biology International Symposium," taking place at the Magdalene College in Cambridge, England, on September 17th and 18th, 2024.
|
It's our pleasure to announce that Clinisciences is participating in the "20th North of England Cell Biology (NECB) Forum" that's going to be held in the National STEM Learning Centre, York, on September 20th 2024.
|
We are delighted to announce the Clinisciences is proud to participate in "The 9th BioProduction Congress", that's going to be held in the "Vinci International Congress Center" in Tours, France from 25th to 26th september 2024.
|
We are excited to announce Clinisciences' participation in the "64th Annual Meeting of the Italian Cancer Society", organized at the University of Milan from September 25th to 27th, 2024.
|
We are thrilled to announce that Clinisciences will be participating in the prestigious "Colloque ATC" congress, taking place at the Pathé Wilson Cinema in Toulouse, France, on September 26th and 27th, 2024.
|
We are thrilled to announce that Clinisciences is proudly sponsoring the German Society for Biochemistry and Molecular Biology Conference, which will take place at the University Hospital in Frankfurt, Germany, from September 25th to 27th, 2024.
|
It's a pleasure to Clinisciences to announce it's participation in the "German Stem Cell Network (GSCN) 12th Conference" , taking place from 25th to 27th September 2024 at the Friedrich Schiller University in Jena.
|
We are excited to share that Clinisciences will be a proud sponsor of The Annual Meeting of the Biotechnology Sector in Portugal. This significant event will be held at the Taguspark Congress Center, in Oeiras Portugal , from September 30th to October 1st, 2024 .
|
Quimigen Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.
|